ArticleLeukemia2016

Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Z Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.